Gi Windows, Inc.
Clinical trials sponsored by Gi Windows, Inc., explained in plain language.
-
Gut reroute procedure shows promise for diabetes control
Disease control OngoingThis study tests a procedure that reroutes part of the small intestine to help control blood sugar in people with type 2 diabetes and obesity. About 15 participants with a BMI between 30 and 50 will be followed for a year to see if their blood sugar and weight improve. The goal i…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New device aims to make weight loss surgery safer and more effective
Disease control OngoingThis study tests a new tool called the SFM Anastomosis Device, used during weight loss surgery to connect parts of the intestine. It involves 28 adults with severe obesity (BMI 35-55) who are either having a sleeve gastrectomy with an added intestinal bypass, or have had a sleeve…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC